Su Zhou YiHua Biotechnology Co. LTD   Report issue

For profit Phase 3
Founded: Suzhou China (1985)

Organization Overview

First Clinical Trial
2015
NCT02380066
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Su Zhou YiHua Biotechnology Co. LTD

Active Ingredients

Drugs in Phase 3 Trials (1)

anyu peibo (3 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Depression (Phase 3)

Depressive Disorder (Phase 3)

Depressive Disorder, Major (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 3
  • # of Trial APIs: 1